Valeant Pharmaceuticals (VRX) Trades Higher Despite Bid
Tweet
Share
E-mail
Surprisingly, Valeant Pharmaceuticals (NYSE: VRX), which launched a massive bid for Cephalon Inc. (Nasdaq: CEPH) after the close, is trading up 15 percent on the news.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic hires Google chip veteran as it pushed into hardware - Bloomberg
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- Apple Cuts Jobs in Siri, Vision Pro 3D Video and Gaming Teams - Bloomberg
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
